Table 4.
Genotype distribution in five genetic models in females.
| Genotype | Genetic model | NAFLD (N) | Non-NAFLD (N) | OR | 95% CI | p | FDR | p1 | FDR1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| rs12409877 | Codominant | 0.089 | 0.111 | 0.034* | 0.043* | |||||
| A/A | 254 | 111 | 1.00 | |||||||
| A/G | 30 | 25 | 1.91 | 1.07 | 3.39 | |||||
| G/G | 3 | 2 | 1.53 | 0.25 | 9.26 | |||||
| Dominant | 0.029* | 0.069 | 0.011* | 0.028* | ||||||
| A/A | 254 | 111 | 1.00 | |||||||
| A/G-G/G | 33 | 27 | 1.87 | 1.07 | 3.26 | |||||
| Overdominant | 0.031* | 0.069 | 0.010* | 0.028* | ||||||
| A/A-G/G | 257 | 113 | 1.00 | |||||||
| A/G | 30 | 25 | 1.90 | 1.07 | 3.37 | |||||
| log-Additive | 0.041* | 0.069 | 0.021* | 0.036* | ||||||
| 0,1,2 | 287 | 138 | 1.68 | 1.03 | 2.76 | |||||
| rs10770141 | Codominant | 0.022* | 0.056 | 0.217 | 0.281 | |||||
| G/G | 255 | 111 | 1.00 | |||||||
| A/G | 33 | 24 | 1.67 | 0.94 | 2.96 | |||||
| A/A | 0 | 2 | 0 | |||||||
| Dominant | 0.040* | 0.067 | 0.225 | 0.281 | ||||||
| G/G | 255 | 111 | 1.00 | |||||||
| A/G-A/A | 33 | 26 | 1.81 | 1.03 | 3.17 | |||||
| log-Additive | 0.022* | 0.056 | 0.167 | 0.281 | ||||||
| 0,1,2 | 288 | 137 | 1.89 | 1.11 | 3.22 | |||||
| rs2292354 | Overdominant | 0.049* | 0.229 | 0.047* | 0.202 | |||||
| G/G-A/A | 218 | 89 | 1.00 | |||||||
| G/A | 81 | 51 | 1.54 | 1.00 | 2.37 | |||||
CI, confidence interval; FDR, false discovery rate; NAFLD, non-alcoholic fatty liver disease; OR, odds ratio; SNPs, single nucleotide polymorphisms.
p1 and FDR1 indicate p value and adjusted p value by FDR method after adjusting age and BMI.
indicate p < 0.05 and p < 0.01, respectively.